Researches

South Egypt Cancer Institute

Assiut University

# Title Department Research Member Research Year
131 Bendamustine in Refractory / Relapsed Non Hodgkin Lymphoma Department of Medical Oncology Dr. Maged Abdelfatah Amine Hassan 2021
132 Ewing sarcoma outcomes in a country with limited resources: Egypt as an example Department of Medical Oncology Dr. Osama mostafa Abdelbadee Abou elhassan 2021
133 HLA-B* 15 predicts survival in Egyptian patients with COVID-19 Department of Clinical Pathology Prof. Douaa Mohamed Sayed Hussein 2021
134 Role of serum miR-21 and miR-92a in colorectal cancer diagnosis as novel molecular biomarkers Department of Surgical Oncology Mohamed Ismail Omar Ali 2021
135 Interleukin-10: A Potential Prognostic Marker in Patients with Newly Diagnosed Multiple Myeloma Department of Medical Oncology Dr. Salah Mabrouk Khallaf Abd Rabou 2021
136 Relation of Estrogen Receptor Expression to Recurrence and Survival in Early and Locally Advanced Breast Cancer
 		Department of Medical Oncology Dr. Mayada Fawzy Sedik Farghaly 2021
137 Role of post-therapy 99mTc-MIBI single-photon emission computed tomography/computed tomography scan in predicting survival in patients with high-grade glioma Department of Radiotherapy and Nuclear medicine Dr. Esraa Roshdy Hassan Mohamed 2021
138 Gastric signet ring cell carcinoma, does it confer a worse prognosis and treatment outcome Department of Radiotherapy and Nuclear medicine Dr. Doaa Mohamed Fouad Mahmoud 2021
139 Higher proportion of non-classical and intermediate monocytes in newly diagnosed multiple myeloma patients in Egypt: a possible prognostic marker
 		Department of Medical Oncology Dr. Hanaan Ahmed Mohammed Ahmed 2021
140 Clinical Outcome of Pediatric Acute Myeloid Leukemia Treated at South Egypt Cancer Institute, Assiut University, Egypt Department of Pediatric Oncology Dr. Ahmed Mohammed Morsy Hassan 2021